In a recently published case report of GBM with glial and epithelioid components, the genomic and transcriptomic profiles showed that both glioma and epithelioid sections contained identical point mutations in PTEN, RB1, TERT promoter and TP53. The gene discussed is TP53; the disease is central nervous system cancer.